🇺🇸 AMGN — Amgen Inc.

Salud Mantener
← Volver

Precio actual

460,42 USD

Máx. histórico

478,48

2 días

Split 2:1 del 22/11/1999

Caída desde máximo

-3,77%

Rango 52 semanas

312,39 – 483,99

Variación hoy

+0,03%

Cierre anterior

460,28

Rango de hoy

447,04 – 462,91

Volumen hoy

2.578.799

Peor caída histórica

-78,03%

17/06/1983 → 19/11/1984

Recuperado en 487 días

Volatilidad anualizada ⓘ

37,46%

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
26,69 (puede no estar actualizado)
Dividend yield
2,19% (puede no estar actualizado)
Precio objetivo analistas
409,63 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 16 horas
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,16%
Fecha de pago Importe por participación
21/08/2026 2,5200 USD
15/05/2026 2,5200 USD
13/02/2026 2,5200 USD
21/11/2025 2,3800 USD
22/08/2025 2,3800 USD
16/05/2025 2,3800 USD
14/02/2025 2,3800 USD
18/11/2024 2,2500 USD
16/08/2024 2,2500 USD
16/05/2024 2,2500 USD
15/02/2024 2,2500 USD
16/11/2023 2,1300 USD
17/08/2023 2,1300 USD
17/05/2023 2,1300 USD
14/02/2023 2,1300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
22/11/1999 2:1
01/03/1999 2:1
16/08/1995 2:1
11/09/1991 3:1
13/08/1990 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/03/2007 62,08 62,55 61,72 62,02 -0,45% 1,34% 13.249.900
06/03/2007 62,29 62,66 61,70 62,30 +0,23% 1,54% 12.493.100
05/03/2007 61,62 63,15 61,10 62,16 +0,66% 3,33% 17.479.100
02/03/2007 62,11 62,45 61,40 61,75 +0,08% 1,69% 21.136.500
01/03/2007 62,40 62,89 61,41 61,70 -3,98% 2,37% 38.347.100
28/02/2007 65,00 65,22 64,15 64,26 +0,02% 1,65% 16.460.200
27/02/2007 65,35 65,52 63,86 64,25 -2,95% 2,54% 22.702.700
26/02/2007 66,15 66,50 65,96 66,20 -0,05% 0,82% 10.838.300
23/02/2007 66,50 67,50 65,96 66,23 -0,76% 2,32% 19.424.100
22/02/2007 66,84 67,41 66,62 66,74 -0,99% 1,18% 14.397.900
21/02/2007 66,01 67,62 65,72 67,41 +1,60% 2,88% 16.658.300
20/02/2007 66,65 67,18 66,25 66,35 -0,57% 1,40% 17.507.200
16/02/2007 68,22 68,49 65,94 66,73 -2,27% 3,74% 30.258.500
15/02/2007 68,70 68,92 67,91 68,28 -0,76% 1,47% 11.571.400
14/02/2007 68,72 69,11 68,68 68,80 +0,00% 0,63% 10.553.100
13/02/2007 68,73 68,98 68,50 68,80 +0,45% 0,70% 6.197.000
12/02/2007 69,41 69,53 68,42 68,49 -0,81% 1,60% 6.831.800
09/02/2007 69,95 70,09 69,00 69,05 -1,05% 1,56% 10.375.300
08/02/2007 69,59 70,39 69,55 69,78 -0,31% 1,21% 8.879.900
07/02/2007 69,30 70,25 69,30 70,00 +0,49% 1,37% 7.881.100
06/02/2007 70,33 70,49 69,23 69,66 -0,26% 1,79% 9.683.100
05/02/2007 69,44 70,21 69,05 69,84 +0,56% 1,67% 9.181.200
02/02/2007 69,68 70,01 69,40 69,45 -0,06% 0,88% 10.115.500
01/02/2007 70,19 70,25 69,02 69,49 -1,25% 1,75% 13.779.600
31/01/2007 70,40 70,57 69,90 70,37 +0,06% 0,95% 8.537.800
30/01/2007 70,68 71,13 70,23 70,33 +0,51% 1,27% 11.686.000
29/01/2007 71,20 71,30 69,86 69,97 -2,14% 2,02% 13.797.900
26/01/2007 71,69 71,89 70,92 71,50 -4,48% 1,35% 30.276.300
25/01/2007 74,83 75,01 74,32 74,85 -0,39% 0,92% 10.974.200
24/01/2007 74,45 75,14 74,00 75,14 +0,72% 1,53% 7.198.900